HESI LPN
Leadership and Management HESI Test Bank
1. Your pediatric patient weighs 15.8 kg. How many pounds does this child weigh?
- A. 36 pounds
- B. 33.6 pounds
- C. 35 pounds
- D. 34.8 pounds
Correct answer: D
Rationale: To convert 15.8 kg to pounds, you multiply by the conversion factor of 2.20462. So, 15.8 kg * 2.20462 = 34.8 pounds. Therefore, the child weighs 34.8 pounds. Choice A is incorrect as it is higher than the correct answer. Choice B is incorrect as it is lower than the correct answer. Choice C is incorrect as it rounds down the conversion result, leading to an inaccurate weight measurement.
2. Which of the following is a benefit of the U.S. health-care system?
- A. With cost savings from technology, more Americans now have health-care insurance.
- B. Quality of care has improved in the United States.
- C. Care in the United States has shifted to a prevention focus rather than an illness focus.
- D. The use of technology is projected to decrease health-care costs and improve clinical outcomes.
Correct answer: D
Rationale: The correct answer is D because the use of technology and electronic health records is projected to decrease health-care costs and improve clinical outcomes, quality, and safety. Choice A is incorrect because it states that very few Americans have no health-care insurance, which is not a benefit of the U.S. health-care system. Choice B may be true, but it does not directly address a benefit of the health-care system. Choice C is not necessarily a benefit but rather a shift in focus, so it is also incorrect.
3. Your patient has been diagnosed with giant cell arthritis. What medication will this patient most likely be given?
- A. High doses of aspirin
- B. High doses of prednisone
- C. Methotrexate
- D. Albuterol
Correct answer: B
Rationale: High doses of prednisone are commonly prescribed for giant cell arthritis to reduce inflammation. Aspirin is not typically used for this condition. Methotrexate is more commonly used for conditions like rheumatoid arthritis, not giant cell arthritis. Albuterol is a bronchodilator used for respiratory conditions, not for giant cell arthritis.
4. Your patient has a blood potassium level of 9.2 mEq/L. What intervention should you anticipate for this patient?
- A. Intravenous potassium supplementation
- B. Intravenous calcium supplementation
- C. Kidney dialysis
- D. Parenteral nutrition
Correct answer: C
Rationale: The correct answer is C: Kidney dialysis. A blood potassium level of 9.2 mEq/L indicates severe hyperkalemia, which can be life-threatening. Kidney dialysis is the most appropriate intervention to rapidly lower potassium levels in this situation. Choice A, intravenous potassium supplementation, would worsen the hyperkalemia. Choice B, intravenous calcium supplementation, is not the primary intervention for hyperkalemia. Choice D, parenteral nutrition, is unrelated to treating hyperkalemia and would not address the immediate concern.
5. The doctor has ordered 20 cc per hour of normal saline intravenously for your pediatric patient. You will be using pediatric intravenous tubing that delivers 60 cc per drop. How many drops per minute will you administer using this pediatric intravenous set?
- A. 30 drops per minute
- B. 25 drops per minute
- C. 20 drops per minute
- D. 22 drops per minute
Correct answer: C
Rationale: To calculate the drops per minute, first convert the ordered amount to drops per minute. 20 cc per hour equals 20 drops per hour with 60 cc per drop tubing, which is equivalent to 20 drops per hour * 60 cc per drop = 1200 drops per hour. To find drops per minute, divide 1200 by 60 (minutes in an hour), which equals 20 drops per minute. Therefore, the correct answer is 20 drops per minute. Choices A, B, and D are incorrect as they do not reflect the correct calculation based on the provided information.
Similar Questions
Access More Features
HESI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access